This report provides a comprehensive analysis of the global wearable electroencephalography (EEG) market, tracing its trajectory from 2025 through 2032. It examines non-invasive brainwave recording technologies, segmenting the industry by type, such as dry and wet power systems, and application, including hospitals and clinics. By evaluating key players like Nihon Kohden and Medtronic, the study highlights regional growth across the Americas, APAC, and Europe, offering strategic insights into market drivers and emerging opportunities.

Market Overview

The global Wearable Electroencephalography market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate during the forecast period from 2026 to 2032.

Technology Definition: Wearable Electroencephalography (EEG) is a technology designed to record the electrical activity of the brain using portable, user-friendly devices that can be worn on the head or other parts of the body. These devices capture brainwave data non-invasively through electrodes placed on the scalp.

Regional Market Analysis

The report provides detailed outlooks for several key geographic regions, noting expected growth and expansion between 2025 and 2032:

• United States: The market is estimated to increase steadily from 2025 through 2032.
• China: The market is estimated to increase steadily from 2025 through 2032.
• Europe: The market is estimated to increase steadily from 2025 through 2032.

Market Segmentation

This report provides a detailed analysis of the Wearable Electroencephalography industry, broken down by the following segments:

By Type

• Dry Power Systems
• Wet Power Level System
• Others

By Application

• Hospital
• Clinic
• Institution
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Market Dynamics

The report highlights key trends related to product segmentation, company formation, revenue, and market share, as well as the latest developments and M&A activity. It further analyzes the strategies of leading global companies, focusing on their Wearable Electroencephalography portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolio, and market penetration:

• Nihon Kohden
• Natus
• Medtronic
• Masimo
• Micromed
• EGI
• Texas Instruments
• Cadwell
• Neurosoft
• Dreem
• Emotiv
• NeuroSky
• OpenBCI
• EB Neuro
• NCC Medical
• Compumedics
• Neuracle
• Symtop
• Haishen Medical
• Million
• Contec
• Solar Medical
• Neurable
• Muse
• g.tec
• BrainCo

Market Concentration: In 2025, the two largest global companies in this sector occupied a significant portion of the total market share.

About the Research Report

Produced by LP Information, Inc. (LPI), the “Wearable Electroencephalography Industry Forecast” reviews total world sales in 2025 and provides a comprehensive analysis of projected sales for 2026 through 2032. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry. The report provides detailed analysis in US$ millions across regions, market sectors, and sub-sectors.

Key Questions Addressed

• What is the 10-year outlook for the global Wearable Electroencephalography market?
• What factors are driving Wearable Electroencephalography market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Wearable Electroencephalography market opportunities vary by end market size?
• How does Wearable Electroencephalography break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Wearable Electroencephalography Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Wearable Electroencephalography by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Wearable Electroencephalography by Country/Region, 2021, 2025 & 2032

  • 2.2 Wearable Electroencephalography Segment by Type

    • 2.2.1 Dry Power Systems

    • 2.2.2 Wet Power Level System

    • 2.2.3 Others

    • 2.2.4 Wearable Electroencephalography Sales by Type

      • 2.2.4.1 Global Wearable Electroencephalography Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Wearable Electroencephalography Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Wearable Electroencephalography Sale Price by Type (2021-2026)

  • 2.3 Wearable Electroencephalography Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Institution

    • 2.3.4 Others

    • 2.3.5 Wearable Electroencephalography Sales by Application

      • 2.3.5.1 Global Wearable Electroencephalography Sale Market Share by Application (2021-2026)
      • 2.3.5.2 Global Wearable Electroencephalography Revenue and Market Share by Application (2021-2026)
      • 2.3.5.3 Global Wearable Electroencephalography Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Wearable Electroencephalography Breakdown Data by Company

    • 3.1.1 Global Wearable Electroencephalography Annual Sales by Company (2021-2026)

    • 3.1.2 Global Wearable Electroencephalography Sales Market Share by Company (2021-2026)

  • 3.2 Global Wearable Electroencephalography Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Wearable Electroencephalography Revenue by Company (2021-2026)

    • 3.2.2 Global Wearable Electroencephalography Revenue Market Share by Company (2021-2026)

  • 3.3 Global Wearable Electroencephalography Sale Price by Company

  • 3.4 Key Manufacturers Wearable Electroencephalography Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Wearable Electroencephalography Product Location Distribution

    • 3.4.2 Players Wearable Electroencephalography Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Wearable Electroencephalography by Geographic Region

  • 4.1 World Historic Wearable Electroencephalography Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Wearable Electroencephalography Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Wearable Electroencephalography Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Wearable Electroencephalography Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Wearable Electroencephalography Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Wearable Electroencephalography Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Wearable Electroencephalography Sales Growth

  • 4.4 APAC Wearable Electroencephalography Sales Growth

  • 4.5 Europe Wearable Electroencephalography Sales Growth

  • 4.6 Middle East & Africa Wearable Electroencephalography Sales Growth

• 5 Americas

  • 5.1 Americas Wearable Electroencephalography Sales by Country

    • 5.1.1 Americas Wearable Electroencephalography Sales by Country (2021-2026)

    • 5.1.2 Americas Wearable Electroencephalography Revenue by Country (2021-2026)

  • 5.2 Americas Wearable Electroencephalography Sales by Type (2021-2026)

  • 5.3 Americas Wearable Electroencephalography Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Wearable Electroencephalography Sales by Region

    • 6.1.1 APAC Wearable Electroencephalography Sales by Region (2021-2026)

    • 6.1.2 APAC Wearable Electroencephalography Revenue by Region (2021-2026)

  • 6.2 APAC Wearable Electroencephalography Sales by Type (2021-2026)

  • 6.3 APAC Wearable Electroencephalography Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Wearable Electroencephalography by Country

    • 7.1.1 Europe Wearable Electroencephalography Sales by Country (2021-2026)

    • 7.1.2 Europe Wearable Electroencephalography Revenue by Country (2021-2026)

  • 7.2 Europe Wearable Electroencephalography Sales by Type (2021-2026)

  • 7.3 Europe Wearable Electroencephalography Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Wearable Electroencephalography by Country

    • 8.1.1 Middle East & Africa Wearable Electroencephalography Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Wearable Electroencephalography Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Wearable Electroencephalography Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Wearable Electroencephalography Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Wearable Electroencephalography

  • 10.3 Manufacturing Process Analysis of Wearable Electroencephalography

  • 10.4 Industry Chain Structure of Wearable Electroencephalography

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Wearable Electroencephalography Distributors

  • 11.3 Wearable Electroencephalography Customer

• 12 World Forecast Review for Wearable Electroencephalography by Geographic Region

  • 12.1 Global Wearable Electroencephalography Market Size Forecast by Region

    • 12.1.1 Global Wearable Electroencephalography Forecast by Region (2027-2032)

    • 12.1.2 Global Wearable Electroencephalography Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Wearable Electroencephalography Forecast by Type (2027-2032)

  • 12.7 Global Wearable Electroencephalography Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Nihon Kohden

    • 13.1.1 Nihon Kohden Company Information

    • 13.1.2 Nihon Kohden Wearable Electroencephalography Product Portfolios and Specifications

    • 13.1.3 Nihon Kohden Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Nihon Kohden Main Business Overview

    • 13.1.5 Nihon Kohden Latest Developments

  • 13.2 Natus

    • 13.2.1 Natus Company Information

    • 13.2.2 Natus Wearable Electroencephalography Product Portfolios and Specifications

    • 13.2.3 Natus Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Natus Main Business Overview

    • 13.2.5 Natus Latest Developments

  • 13.3 Medtronic

    • 13.3.1 Medtronic Company Information

    • 13.3.2 Medtronic Wearable Electroencephalography Product Portfolios and Specifications

    • 13.3.3 Medtronic Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Medtronic Main Business Overview

    • 13.3.5 Medtronic Latest Developments

  • 13.4 Masimo

    • 13.4.1 Masimo Company Information

    • 13.4.2 Masimo Wearable Electroencephalography Product Portfolios and Specifications

    • 13.4.3 Masimo Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Masimo Main Business Overview

    • 13.4.5 Masimo Latest Developments

  • 13.5 Micromed

    • 13.5.1 Micromed Company Information

    • 13.5.2 Micromed Wearable Electroencephalography Product Portfolios and Specifications

    • 13.5.3 Micromed Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Micromed Main Business Overview

    • 13.5.5 Micromed Latest Developments

  • 13.6 EGI

    • 13.6.1 EGI Company Information

    • 13.6.2 EGI Wearable Electroencephalography Product Portfolios and Specifications

    • 13.6.3 EGI Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 EGI Main Business Overview

    • 13.6.5 EGI Latest Developments

  • 13.7 Texas Instruments

    • 13.7.1 Texas Instruments Company Information

    • 13.7.2 Texas Instruments Wearable Electroencephalography Product Portfolios and Specifications

    • 13.7.3 Texas Instruments Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Texas Instruments Main Business Overview

    • 13.7.5 Texas Instruments Latest Developments

  • 13.8 Cadwell

    • 13.8.1 Cadwell Company Information

    • 13.8.2 Cadwell Wearable Electroencephalography Product Portfolios and Specifications

    • 13.8.3 Cadwell Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Cadwell Main Business Overview

    • 13.8.5 Cadwell Latest Developments

  • 13.9 Neurosoft

    • 13.9.1 Neurosoft Company Information

    • 13.9.2 Neurosoft Wearable Electroencephalography Product Portfolios and Specifications

    • 13.9.3 Neurosoft Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Neurosoft Main Business Overview

    • 13.9.5 Neurosoft Latest Developments

  • 13.10 Dreem

    • 13.10.1 Dreem Company Information

    • 13.10.2 Dreem Wearable Electroencephalography Product Portfolios and Specifications

    • 13.10.3 Dreem Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Dreem Main Business Overview

    • 13.10.5 Dreem Latest Developments

  • 13.11 Emotiv

    • 13.11.1 Emotiv Company Information

    • 13.11.2 Emotiv Wearable Electroencephalography Product Portfolios and Specifications

    • 13.11.3 Emotiv Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Emotiv Main Business Overview

    • 13.11.5 Emotiv Latest Developments

  • 13.12 NeuroSky

    • 13.12.1 NeuroSky Company Information

    • 13.12.2 NeuroSky Wearable Electroencephalography Product Portfolios and Specifications

    • 13.12.3 NeuroSky Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 NeuroSky Main Business Overview

    • 13.12.5 NeuroSky Latest Developments

  • 13.13 OpenBCI

    • 13.13.1 OpenBCI Company Information

    • 13.13.2 OpenBCI Wearable Electroencephalography Product Portfolios and Specifications

    • 13.13.3 OpenBCI Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 OpenBCI Main Business Overview

    • 13.13.5 OpenBCI Latest Developments

  • 13.14 EB Neuro

    • 13.14.1 EB Neuro Company Information

    • 13.14.2 EB Neuro Wearable Electroencephalography Product Portfolios and Specifications

    • 13.14.3 EB Neuro Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 EB Neuro Main Business Overview

    • 13.14.5 EB Neuro Latest Developments

  • 13.15 NCC Medical

    • 13.15.1 NCC Medical Company Information

    • 13.15.2 NCC Medical Wearable Electroencephalography Product Portfolios and Specifications

    • 13.15.3 NCC Medical Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 NCC Medical Main Business Overview

    • 13.15.5 NCC Medical Latest Developments

  • 13.16 Compumedics

    • 13.16.1 Compumedics Company Information

    • 13.16.2 Compumedics Wearable Electroencephalography Product Portfolios and Specifications

    • 13.16.3 Compumedics Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Compumedics Main Business Overview

    • 13.16.5 Compumedics Latest Developments

  • 13.17 Neuracle

    • 13.17.1 Neuracle Company Information

    • 13.17.2 Neuracle Wearable Electroencephalography Product Portfolios and Specifications

    • 13.17.3 Neuracle Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Neuracle Main Business Overview

    • 13.17.5 Neuracle Latest Developments

  • 13.18 Symtop

    • 13.18.1 Symtop Company Information

    • 13.18.2 Symtop Wearable Electroencephalography Product Portfolios and Specifications

    • 13.18.3 Symtop Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Symtop Main Business Overview

    • 13.18.5 Symtop Latest Developments

  • 13.19 Haishen Medical

    • 13.19.1 Haishen Medical Company Information

    • 13.19.2 Haishen Medical Wearable Electroencephalography Product Portfolios and Specifications

    • 13.19.3 Haishen Medical Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 Haishen Medical Main Business Overview

    • 13.19.5 Haishen Medical Latest Developments

  • 13.20 Million

    • 13.20.1 Million Company Information

    • 13.20.2 Million Wearable Electroencephalography Product Portfolios and Specifications

    • 13.20.3 Million Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 Million Main Business Overview

    • 13.20.5 Million Latest Developments

  • 13.21 Contec

    • 13.21.1 Contec Company Information

    • 13.21.2 Contec Wearable Electroencephalography Product Portfolios and Specifications

    • 13.21.3 Contec Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.21.4 Contec Main Business Overview

    • 13.21.5 Contec Latest Developments

  • 13.22 Solar Medical

    • 13.22.1 Solar Medical Company Information

    • 13.22.2 Solar Medical Wearable Electroencephalography Product Portfolios and Specifications

    • 13.22.3 Solar Medical Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.22.4 Solar Medical Main Business Overview

    • 13.22.5 Solar Medical Latest Developments

  • 13.23 Neurable

    • 13.23.1 Neurable Company Information

    • 13.23.2 Neurable Wearable Electroencephalography Product Portfolios and Specifications

    • 13.23.3 Neurable Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.23.4 Neurable Main Business Overview

    • 13.23.5 Neurable Latest Developments

  • 13.24 Muse

    • 13.24.1 Muse Company Information

    • 13.24.2 Muse Wearable Electroencephalography Product Portfolios and Specifications

    • 13.24.3 Muse Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.24.4 Muse Main Business Overview

    • 13.24.5 Muse Latest Developments

  • 13.25 g.tec

    • 13.25.1 g.tec Company Information

    • 13.25.2 g.tec Wearable Electroencephalography Product Portfolios and Specifications

    • 13.25.3 g.tec Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.25.4 g.tec Main Business Overview

    • 13.25.5 g.tec Latest Developments

  • 13.26 BrainCo

    • 13.26.1 BrainCo Company Information

    • 13.26.2 BrainCo Wearable Electroencephalography Product Portfolios and Specifications

    • 13.26.3 BrainCo Wearable Electroencephalography Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.26.4 BrainCo Main Business Overview

    • 13.26.5 BrainCo Latest Developments

• 14 Research Findings and Conclusion